Waldencast agrees to sell Obagi Medical to Bridgepoint for up to $460 million
Waldencast plc (NASDAQ: WALD) announced it entered into a definitive agreement to sell its Obagi Medical dermatological skincare business to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
